More details have started to emerge on how exactly Bayer is executing its broader company restructuring.
The German conglomerate disclosed that 1,500 full-time employees had been laid off across pharmaceuticals, crop science and consumer health at the end of the first quarter. The company previously described plans for staff cuts in January but did not provide details on numbers.
CEO Bill Anderson told media on Tuesday morning that, while it does not have a breakdown of the worker cuts by division, it was likely proportional to each division’s representation across the company.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.